Market Research; Manufacturing; Medical Device; Pharmaceutical; Financial Services; Service; Retail; Research; Computer Software; Diagnostic; Health Care; Transportation; Biotech; Clinical Research; Consulting; Distribution; Insurance; Hospitality; Telecommunications; Technology; Professional Services; High Tech; Automobile; Utilities; Energy; Consumer Products; Chemical; Medical; Electronics; Laboratories; Banking; Computers; Entertainment; Internet; Computer Hardware; Aerospace; Academic; Media; Education; Newspapers; Government; Shipping; Science; Office Supplies; Marketing; Office Equipment; Cable; Advertising; Defense; Military; Diversified; Sports; Biopharmaceutical; Technology; Multiple; Communications; Logistics; Publishing; Public Relations; Real Estate; Construction; Architecture; Engineering; Aviation; Legal; Test Industry; Non-Profit; Business; Orthopaedics
This 13-slide Executive Presentation reveals how six leading pharmaceutical companies effectively manage market planning for oncology products during Phase II and Phase III clinical trials.
Drawn from primary interviews with oncology product managers, the study highlights the following key aspects of oncology product marketing:
Overall, the presentation includes:
- effective advisory board approaches used by benchmarking companies
- the three distinct approaches in registering and launching multiple targeted therapies
- new clinical trial endpoints used by benchmarking companies
- critical factors that affect a product's ability to quickly reach peak sales
Four key findings summarize the insights drawn from benchmark companies' new oncology product market planning programs.
- 6 Information Graphics
- 2 Data Graphics
- 9 Manager or Executive Narratives
- 7 Metrics